Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ronald C Chen
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
79 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kingman Regional Medical Center
Kingman, Arizona, United States
- Kaiser Permanente Dublin
Dublin, California, United States
- Kaiser Permanente Oakland-Broadway
Oakland, California, United States
- Kaiser Permanente-Rancho Cordova Cancer Center
Rancho Cordova, California, United States
- Rohnert Park Cancer Center
Rohnert Park, California, United States
- the Permanente Medical Group-Roseville Radiation Oncology
Roseville, California, United States
- Kaiser Permanente Medical Center - Santa Clara
Santa Clara, California, United States
- Kaiser Permanente Cancer Treatment Center
South San Francisco, California, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Helen F Graham Cancer Center
Newark, Delaware, United States
- Beebe Health Campus
Rehoboth Beach, Delaware, United States
- Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States
- Augusta University Medical Center
Augusta, Georgia, United States
- Saint Luke'S Cancer Institute - Boise
Boise, Idaho, United States
- Saint Luke'S Cancer Institute - Fruitland
Fruitland, Idaho, United States
- Saint Luke'S Cancer Institute - Meridian
Meridian, Idaho, United States
- Saint Luke'S Cancer Institute - Nampa
Nampa, Idaho, United States
- Saint Luke'S Cancer Institute - Twin Falls
Twin Falls, Idaho, United States
- John H Stroger Jr Hospital of Cook County
Chicago, Illinois, United States
- Carle at the Riverfront
Danville, Illinois, United States
- Cancer Care Specialists of Illinois - Decatur
Decatur, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Carle Physician Group-Effingham
Effingham, Illinois, United States
- Crossroads Cancer Center
Effingham, Illinois, United States
- Carle Physician Group-Mattoon/charleston
Mattoon, Illinois, United States
- Ssm Health Good Samaritan
Mount Vernon, Illinois, United States
- Carle Cancer Center
Urbana, Illinois, United States
- Saint Luke'S Hospital
Cedar Rapids, Iowa, United States
- University of Kansas Clinical Research Center
Fairway, Kansas, United States
- University of Kansas Cancer Center
Kansas City, Kansas, United States
- University of Kansas Cancer Center-West
Kansas City, Kansas, United States
- University of Kansas Cancer Center-Overland Park
Overland Park, Kansas, United States
- University of Kansas Health System Saint Francis Campus
Topeka, Kansas, United States
- University of Kansas Hospital-Westwood Cancer Center
Westwood, Kansas, United States
- Mainehealth Coastal Cancer Treatment Center
Bath, Maine, United States
- Mainehealth Maine Medical Center - Portland
Portland, Maine, United States
- Mainehealth Cancer Care Center of York County
Sanford, Maine, United States
- Mainehealth Maine Medical Center- Scarborough
Scarborough, Maine, United States
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital
Grand Rapids, Michigan, United States
- Minnesota Oncology Hematology Pa-Maplewood
Maplewood, Minnesota, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Jul 2019
- Primary completion
- 14 Nov 2024
- Completion
- 4 Sept 2025
- Last update posted
- 3 Nov 2025
- Registered enrollment
- 550
- Registry id
- NCT03860961
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.